|
CTNND1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.362610E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.265400E-01 |
| Normal-vs-Stage2 |
9.376500E-03 |
| Normal-vs-Stage3 |
3.04449999999346E-06 |
| Normal-vs-Stage4 |
2.03869999999551E-05 |
| Stage1-vs-Stage2 |
2.135600E-02 |
| Stage1-vs-Stage3 |
3.76539999999981E-05 |
| Stage1-vs-Stage4 |
9.82939999999433E-05 |
| Stage2-vs-Stage3 |
4.869600E-01 |
| Stage2-vs-Stage4 |
3.646400E-01 |
| Stage3-vs-Stage4 |
7.111200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.324600E-03 |
| Normal-vs-AfricanAmerican |
1.396510E-04 |
| Normal-vs-Asian |
5.354800E-01 |
| Caucasian-vs-AfricanAmerican |
1.757910E-02 |
| Caucasian-vs-Asian |
9.255600E-01 |
| AfricanAmerican-vs-Asian |
4.259000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.427000E-04 |
| Normal-vs-Female |
7.945500E-02 |
| Male-vs-Female |
7.720300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.712400E-02 |
| Normal-vs-Age(41-60Yrs) |
1.099420E-01 |
| Normal-vs-Age(61-80Yrs) |
1.597890E-04 |
| Normal-vs-Age(81-100Yrs) |
4.044100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.650600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.695400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.052400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.107500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.676000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.094200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.901500E-02 |
| Normal-vs-Grade 2 |
6.143200E-01 |
| Normal-vs-Grade 3 |
3.563200E-04 |
| Normal-vs-Grade 4 |
2.14099959983116E-10 |
| Grade 1-vs-Grade 2 |
1.156440E-01 |
| Grade 1-vs-Grade 3 |
4.000800E-03 |
| Grade 1-vs-Grade 4 |
2.28999999996038E-06 |
| Grade 2-vs-Grade 3 |
9.352900E-04 |
| Grade 2-vs-Grade 4 |
9.95999949182647E-10 |
| Grade 3-vs-Grade 4 |
9.93179999999594E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.175780E-01 |
| Normal-vs-ccB subtype |
2.29469999668552E-08 |
| ccA subtype-vs-ccB subtype |
2.19824158875781E-14 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.498600E-03 |
| Normal-vs-N1 |
8.982300E-03 |
| N0-vs-N1 |
6.111900E-02 |
|
|
